Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02390011 · ClinicalTrials.gov registry record
Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies
A clinical trial of Neoplams, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT02390011 is a study of Neoplams that has completed, run by University of California, San Francisco. The registered enrollment target is 7 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02390011, a study of Neoplams, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center pilot study testing the use of novel coil arrays with MR liver imaging. In part A of the study, up to 30 healthy volunteers will be scanned, with iterative adjustment of coil array geometry and design to optimize imaging characterstics. In Part B of the study, 40 patients with advanced solid tumors and at least one liver metastasis measuring \> 1.5 cm in diameter on standard anatomic scans will undergo MR liver imaging with the newly designed coil array, with the use of gadolinium contrast. Patients with liver tumors will have the option of undergoing a second MR liver scan during the course of subsequent systemic therapy.
Conditions Studied
Interventions
- PROCEDURE MRI
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-01-08 |
| Est. Completion | 2015-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02390011
The ClinicalTrials.gov registry entry for NCT02390011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplams appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT02390011 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02390011 about?
NCT02390011 is a clinical study titled "Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies". This is a single center pilot study testing the use of novel coil arrays with MR liver imaging. In part A of the study, up to 30 healthy volunteers will be scanned, with iterative adjustment of coil array geometry and design to optimize imaging characterstics. In Part B of the study, 40 patients wit...
What is the current status of trial NCT02390011?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2015-01-08. Estimated completion is 2015-05-16.
What conditions does trial NCT02390011 study?
This clinical trial studies the following conditions: Neoplams.
What interventions are being tested in trial NCT02390011?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02390011?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02390011 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplams
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.